Vertex Pharmaceuticals ROI - Return on Investment 2010-2024 | VRTX

Vertex Pharmaceuticals return on investment for the quarter ending September 30, 2024 was -2.83.

  • Vertex Pharmaceuticals average return on investment for 2023 was 22.79, a 13.41% decline from 2022.
  • Vertex Pharmaceuticals average return on investment for 2022 was 26.32, a 6.69% decline from 2021.
  • Vertex Pharmaceuticals average return on investment for 2021 was 24.67, a 19.67% increase from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Vertex Pharmaceuticals ROI - Return on Investment 2010-2024 | VRTX

  • Vertex Pharmaceuticals average return on investment for 2023 was 22.79, a 13.41% decline from 2022.
  • Vertex Pharmaceuticals average return on investment for 2022 was 26.32, a 6.69% decline from 2021.
  • Vertex Pharmaceuticals average return on investment for 2021 was 24.67, a 19.67% increase from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.